by Vora Corporate Finance | May 28, 2021 | Financial Advisory, Insights, Merger & Acquisitions, Private Equity & IPO
Indian Economy’s recovery pace moderated in April on account of 2nd Covid-19 wave with record infections. Markets remained stable in this month but two IPOs were listed at discount. Key Deals include BYJU’S to acquire Aakash, Piramal to Acquire Hemmo Pharmaceuticals...
by Vora Corporate Finance | Jan 16, 2021 | Insights, Private Equity & IPO
Biocon Ltd., a bio-pharmaceutical company, announced that the Board of its subsidiary Biocon Biologics Ltd (Biocon Biologics) has approved a Rs.1,125 Crore (approx. USD 150 million) fund raise from Goldman Sachs. As per the proposed terms, Goldman Sachs will be issued...
by Karan Vora | Feb 26, 2020 | Insights
The first advance estimates (FAE) released by the National Statistical Office (NSO) on January 7, 2020 placed India’s real gross domestic product (GDP) growth for 2019-20 at 5.0 per cent. In its January 31 release, the NSO revised real GDP growth for 2018-19 to 6.1...
by Karan Vora | Nov 7, 2019 | Insights
Government presented Union Budget 2019-20 in July amidst challenging global environment and notable slowdown in GDP growth rate of India. The chief economic advisor has set the goal in economic survey to make India a 5 Trillion $ economy by 2025. Emphasis has been...
by Karan Vora | Oct 17, 2019 | Insights
In wake of IL&FS and banking sector crisis the Indian economy is slowing down its pace primarily due to liquidity crunch. The estimated growth rate of economy has also been revised to 7% from 7.2% in April by RBI. The Indian economy has grown by 6.8 per cent in...
